Thema
Journal Article
1.578
Research Support, Non-U.S. Gov't
582
615
223
che
208
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
197
Research Support, N.I.H., Extramural
145
Comparative Study
94
Multicenter Study
89
Randomized Controlled Trial
87
A61P: Specific therapeutic activity of chemical compounds or medicinal preparations
84
Case Reports
73
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
72
A61Q: Specific use of cosmetics or similar toilet preparations
71
Observational Study
66
tec
60
Biomarkers
54
Review
52
Letter
51
A23L: Foods, foodstuffs, or non-alcoholic beverages, not covered by subclasses a21d or a23b-a23j; their preparation or treatment, e.g. cooking, modification of nutritive qualities, physical treatment (shaping or working, not fully covered by this subclass, a23p); preservation of foods or foodstuffs, in general
45
Prognosis
36
Children
33
Cytokines
29
EC 3.4.24.69
27
bio
26
Biomarkers, Tumor
25
C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000)
25
Plant Extracts
25
Antineoplastic Agents
24
Magnetic resonance imaging
22
RNA, Messenger
22
Bone mineral density
21
Klinische Studie
21
Botulinum Toxins
20
Silver
20
Validation Study
19
3M4G523W1G
18
COPD
18
EC 2.7.10.1
18
atopic dermatitis
18
Published Erratum
17
Bronchodilator Agents
16
Chronic obstructive pulmonary disease
16
EC 2.7.11.1
16
Evaluation Study
16
Silver nanoparticles
16
Tumor Necrosis Factor-alpha
16
Anti-Inflammatory Agents
15
Biology
15
Membrane Proteins
15
Osteoporosis
15
mehr ...